BioCentury | Jul 16, 2012
Company News
Emergent BioSolutions, Prokarium deal
...Emergent's Typhella Salmonella-based typhoid vaccine and spi-VEC genetic technology. Prokarium said it plans to combine Typhella...
...that uses attenuated Salmonella, which the company then plans to license. Details were not disclosed. Typhella...
...Emergent acquired spi-VEC, which allows for the oral delivery strain of S. typhi used in Typhella...
...that uses attenuated Salmonella, which the company then plans to license. Details were not disclosed. Typhella...
...Emergent acquired spi-VEC, which allows for the oral delivery strain of S. typhi used in Typhella...